Karyopharm Therapeutics I... (KPTI)
Karyopharm Therapeutics Max Pain By Strike
KPTI trades at $6.37, 27.4% above the near-term max pain of $5 expiring Sep 19, 2025 (31 days). Expect downward pressure as dealers benefit from price declining toward max pain. Max pain is rising across expirations ($5-$7.5), reflecting growing call interest at higher strikes. Key magnetic zone at 5 where 2 expirations converge. High dispersion in max pain levels suggests competing forces and potential volatility.
Karyopharm Therapeutics Max Pain By Expiry
Max pain for KPTI shows an upward trend from 5 to 7.5, suggesting bullish positioning in longer-dated options. The 40% spread signals divergent expectations across timeframes. Levels distributed around 6.37. Weekly expirations influence price 2-3 days before expiry; monthlies throughout their final week.
Max Pain Table
| Expiration Date | Max Pain | Max Pain vs Current Price |
|---|---|---|
| Sep 19, 2025 | 5 | -1.37 (-21.51%) |
| Oct 17, 2025 | 7.5 | 1.13 (17.74%) |
| Nov 21, 2025 | 7.5 | 1.13 (17.74%) |
| Feb 20, 2026 | 5 | -1.37 (-21.51%) |